Perindopril Erbumine
3 NDCs across 1 manufacturer|3 Generic,0 Brand
Perindopril Erbumine is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 30, 1993, and the first generic was approved Nov 10, 2009. In 2024, Medicare Part D spent $1 million on Perindopril Erbumine across 20,000 claims for 5,190 beneficiaries.
Perindopril Erbumine is available as 3 NDCs from 1 manufacturer (3 generic, 0 brand), with NADAC prices from $0.49 to $0.54 per EA — a 11% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
3G / 0B
Manufacturers
1
competing in market
Price Spread
$0.49 – $0.54
per EA
7d Activity
avg -0.2% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Aurobindo Pharma Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Angiotensin Converting Enzyme Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing PERINDOPRIL ERBUMINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PERINDOPRIL ERBUMINE 8 MG TAB | $0.5420 per EA | -0.36% |
PERINDOPRIL ERBUMINE 4 MG TAB | $0.4947 per EA | -0.01% |
PERINDOPRIL ERBUMINE 2 MG TAB | $0.4884 per EA | — |
Frequently Asked Questions
What is Perindopril Erbumine used to treat?
Perindopril Erbumine is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
When did Perindopril Erbumine become available as a generic?
FDA approved the first generic Perindopril Erbumine (ANDA) on Nov 10, 2009.
How much does Medicare spend on Perindopril Erbumine?
In 2024, Medicare Part D spent $1 million on Perindopril Erbumine across 20,000 claims for 5,190 beneficiaries.
How many Perindopril Erbumine products are on the market?
The Perindopril Erbumine drug market contains 3 NDCs from 1 manufacturer — 3 generic and 0 brand products.
What is the price range for Perindopril Erbumine?
NADAC reference prices for Perindopril Erbumine range from $0.4884 to $0.5420 per EA — a 11% difference between cheapest and most expensive.
Which manufacturers make Perindopril Erbumine?
1 manufacturer lists Perindopril Erbumine in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (3).
How has the price of Perindopril Erbumine changed recently?
Over the past 7 days, 0 Perindopril Erbumine NDCs rose and 2 fell, with a market-wide average change of -0.2%.